The VEGF Inhibitor Axitinib Has Limited Effectiveness as a Therapy for Adrenocortical Cancer

CONTEXT: Adrenocortical carcinoma (ACC) is a rare malignancy with a poor prognosis in need of more effective treatment options. Published evidence indicates many ACCs express the vascular endothelial growth factor receptor (VEGFR), suggesting inhibiting vascular endothelial growth factor signaling c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: O'Sullivan, Ciara, Edgerly, Maureen, Velarde, Margarita, Wilkerson, Julia, Venkatesan, Aradhana M., Pittaluga, Stefania, Yang, Sherry X., Nguyen, Dat, Balasubramaniam, Sanjeeve, Fojo, Tito
Format: Artigo
Idioma:Inglês
Publicat: Endocrine Society 2014
Matèries:
Endocrine Care
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3973787/
https://ncbi.nlm.nih.gov/pubmed/24423320
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2013-2298
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars